Page 40«..1020..39404142..5060..»

Category Archives: MS Treatment

9 Reasons to Stop Doing Your Own Taxes – The New York Times

Posted: Published on March 5th, 2020

Doing your own taxes really isnt like changing your own oil. Continue reading

Posted in MS Treatment | Comments Off on 9 Reasons to Stop Doing Your Own Taxes – The New York Times

Promising New Treatments for Multiple Sclerosis

Posted: Published on March 4th, 2020

Multiple sclerosis (MS) is a chronic disease that affects the central nervous system. Continue reading

Posted in MS Treatment | Comments Off on Promising New Treatments for Multiple Sclerosis

Waive Fees for Coronavirus Tests and Treatment, Health Experts Urge – The New York Times

Posted: Published on March 4th, 2020

Some legislators particularly those who support expanding public health insurance argue that the government ought to help pay the bills of any patients tested for the coronavirus. There is some precedent for this: In 2015, Congress appropriated millions to reimburse hospitals for the care they provided to Ebola patients. Continue reading

Posted in MS Treatment | Comments Off on Waive Fees for Coronavirus Tests and Treatment, Health Experts Urge – The New York Times

Learn about the Mind, Body, and MS Connection During MSAA’s 2020 MS Awareness Month Campaign – Yahoo Finance

Posted: Published on March 4th, 2020

CHERRY HILL, N.J., March 2, 2020 /PRNewswire/ --The Multiple Sclerosis Association of America (MSAA) recognizes March as Multiple Sclerosis (MS) Awareness Month. Continue reading

Posted in MS Treatment | Comments Off on Learn about the Mind, Body, and MS Connection During MSAA’s 2020 MS Awareness Month Campaign – Yahoo Finance

Patients Receiving Treatment for MS Have Increased Risk for Any Infection – Neurology Advisor

Posted: Published on March 4th, 2020

WEST PALM BEACH Patients who have been diagnosed with and treated for multiple sclerosis (MS) have an increased risk for any type of infection, and are more frequently hospitalized because of infections compared with their health counterparts, according to research presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum held from February 27 to 29, 2020, in West Palm Beach, Florida. Continue reading

Posted in MS Treatment | Comments Off on Patients Receiving Treatment for MS Have Increased Risk for Any Infection – Neurology Advisor

Novartis receives Health Canada approval for Mayzent (siponimod) to treat secondary progressive multiple sclerosis with active disease – Canada…

Posted: Published on March 4th, 2020

"One of the top treatment goals for individuals with MS is delaying disability progression and we're delighted to deliver the first and only oral treatment proven to slow disease progression in those with active SPMS," said Dawn Bell, Chief Scientific Officer and VP Medical Affairs, Novartis Canada. Continue reading

Posted in MS Treatment | Comments Off on Novartis receives Health Canada approval for Mayzent (siponimod) to treat secondary progressive multiple sclerosis with active disease – Canada…

MS News that Caught My Eye Last Week: Remyelination Research in… – Multiple Sclerosis News Today

Posted: Published on March 4th, 2020

In this column, Ill be highlighting some of the research presented at this years Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held last week in West Palm Beach, Florida. Continue reading

Posted in MS Treatment | Comments Off on MS News that Caught My Eye Last Week: Remyelination Research in… – Multiple Sclerosis News Today

AB Science will host a live webcast on masitinib in Progressive Forms of Multiple Sclerosis on Friday March 06, 2020 – Yahoo Finance

Posted: Published on March 4th, 2020

Paris, March 02, 2020, 8.15am AB Science will host a live webcast on masitinib in Progressive Forms of Multiple Sclerosis on Friday March 06, 2020 AB Science SA (NYSE Euronext FR0010557264 AB) is hosting a live webcast on March 06, 2020 with key opinion leaders to discuss recently reported results from the Phase 2B/3 masitinib trial in primary progressive (PPMS) and non-active secondary progressive (nSPMS) multiple sclerosis disclosed on February 20th, and the role that masitinib may play in treating these disorders. The webcast will feature presentations by three Key Opinion Leaders These key opinion leaders will provide: The presentation will be followed by a Q&A session with the key opinion leaders and management of AB Science. Continue reading

Posted in MS Treatment | Comments Off on AB Science will host a live webcast on masitinib in Progressive Forms of Multiple Sclerosis on Friday March 06, 2020 – Yahoo Finance

TG Therapeutics Inc (TGTX) Q4 2019 Earnings Call Transcript – Motley Fool

Posted: Published on March 4th, 2020

Image source: The Motley Fool. TG Therapeutics Inc(NASDAQ:TGTX) Q42019 Earnings Call Mar 3, 2020, 8:00 a.m. Continue reading

Posted in MS Treatment | Comments Off on TG Therapeutics Inc (TGTX) Q4 2019 Earnings Call Transcript – Motley Fool

New injectable HIV treatment to kick off next year- officials – Daily Monitor

Posted: Published on March 4th, 2020

Tuesday March 3 2020 The Director General of Uganda Aids Commission, Dr Nelson Musoba, has said clinical trials on new injectable HIV treatment is being finalised and government will unveil it next year. Continue reading

Posted in MS Treatment | Comments Off on New injectable HIV treatment to kick off next year- officials – Daily Monitor

Page 40«..1020..39404142..5060..»